1267PQUALITY-OF-LIFE (QOL), TOLERABILITY, AND SUPPORTIVE CARE RESULTS: NECITUMUMAB PHASE 3 SQUIRE STUDY
Reck, M., Socinski, M.A., Luft, A., Szczesna, A., Dediu, M., Ramlau, R., Losonczy, G., Molinier, O., Schumann, C., Brown, J., Soldatenkova, V., Chouaki, N., Thatcher, N.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu349.46
Date:
September, 2014
File:
PDF, 68 KB
2014